Modelling forced vital capacity in idiopathic pulmonary fibrosis: optimising trial design. - Santermans, E; Ford, P; Kreuter, M; Verbruggen, N; Meyvisch, P; Wuyts, WA; Brown, KK; Lederer, DJ; Byrne, AJ; Molyneaux, PL; Sivananthan, A; Moor, CC; et al. (Advances in Therapy, 2019)